Amylyx Corp (AMLX) Narx-foyda koeffitsiyenti
Joriy narx-foyda koeffitsiyenti Amylyx Pharmaceuticals (AMLX) kompaniyasining neyroprotektiv ishlanmalariga kiritilgan investitsiyalar tahlilini amalga oshirish imkonini beradi. Kompaniya neyronlarni himoya qilish uchun kombinatsiyalangan terapiyalarni yaratish orqali miya degeneratsiyasini davolashdagi ilmiy salohiyatiga tayanadi. Biroq, asosiy dori vositasining chaqirib olingani bozor ustunliklarini yo'q qildi, bu esa tadqiqot va ishlanmalarni (R&D) qaytadan boshlashni taqozo etdi. Oxirgi parametr -24.00 darajasida bo'lib, bu joriy kapitalizatsiya xatarlariga buyurtmalar kitobining reaksiyasini aks ettiradi.
Amylyx (AMLX) kompaniyasining tahliliy kesimlari
- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi tafsilotlari:
- balans bo'yicha xususiy kapital ma'lumotlari:
- qarz majburiyatlari va likvidlik statistikasi:
Qarzning kapitalga nisbati Amylyx Pharmaceuticals|AMLX - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati ko'rsatkichi Amylyx Corp|AMLX - Kompaniyaning umumiy qarzi|Qarzning sof aktivlarga nisbati Amylyx Pharmaceuticals, Inc.|AMLX - Kompaniyaning uzoq muddatli qarzi|Qisqa muddatli majburiyatlar Amylyx Pharmaceuticals|Oraliq qoplash koeffitsiyenti amylyx.com
- biznes foydasi va investitsiya koeffitsiyentlari ma'lumotlari:
AMLX - Sof foyda|Prognoz qilingan kelajakdagi foyda Amylyx Pharmaceuticals|AMLX - Narxning foydaga nisbati|Kelajakdagi narx-foyda multiplikatori Amylyx Pharmaceuticals Inc|AMLX - Narxning foydaga va o‘sish sur’atiga nisbati|Korxona qiymatining foizlar, soliqlar va amortizatsiyadan oldingi foydaga nisbati koeffitsiyenti Amylyx Pharmaceuticals, Inc.|AMLX - EBITDA operatsion foydasi|Bir aksiya uchun sof foyda (EPS TTM) Amylyx Pharmaceuticals|AMLX - Bir aksiya uchun sof foyda (EPS TTM)|So'nggi 12 oy davomida bir aksiya uchun sof foydaning yillik o'sishi amylyx.com|AMLX - Joriy yilda foyda o'sishi|Keyingi yilda bir aksiya uchun sof foydaning kutilayotgan o'sishi Amylyx Pharmaceuticals
- realizatsiya hajmi va tushum ko'rsatkichlari:
Kompaniyaning umumiy tahlili:amylyx.com - AMLX
Fundamental minimal darajani aniqlash uchun investorga biznes qiymatini narx-foyda koeffitsiyenti orqali baholash zarur bo'lib, bu past baholangan aktivlarni aniqlash imkonini beradi va inqirozga yuz tutgan biznes uchun haddan tashqari ko'p to'lov qilishning oldini oladi. Amylyx Pharmaceuticals (AMLX) kompaniyasining choraklik P/E koeffitsiyentini tahlil qilish orqali bozor kutganlarini ALS terapiyasining haqiqiy tijoratlashtirish samaradorligi va RELYVRIO dori vositasining salohiyati bilan solishtirish, shuningdek, biotexnologiya sektoridagi investitsiyalarning ishonchliligini aniqlash mumkin.
Raqobatdosh kompaniyalar tahlili
P/E multiplikatori biogen.com|Narxning foydaga nisbati Neurocrine Biosciences, Inc. (NBIX)|Narx-foyda koeffitsiyenti Regencell Bioscience Ltd RGC|Axsome Therapeutics Inc - Narx-foyda koeffitsiyenti|ACADIA Corp (ACAD) - Kapitalizatsiyaning foydaga nisbati|XENE - Narxning foydaga nisbati|VKTX: Narxning foydaga nisbati|SUPN (Supernus) - Narx-foyda koeffitsiyenti|Kapitalizatsiyaning foydaga nisbati Catalyst Pharma (CPRX)|Narx-foyda koeffitsiyenti DNLI|Narx-foyda multiplikatori HRMY (Harmony Corp)|Narx-foyda koeffitsiyenti BHVN (Biohaven Ltd.)|TRVI (trevitherapeutics.com) - Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati Praxis Precision Medicines, Inc. PRAX|AVXL (Anavex) - Kapitalizatsiyaning sof foydaga nisbati|CeriBell Corp - P/E multiplikatori|Kompaniya qiymatining sof foydaga nisbati PRTA (Prothena Corporation)|ALEC: P/E multiplikatori|annexonbio.com (ANNX) - P/E multiplikatori|Narxning foydaga nisbati Omeros Corp|NGNE: Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati AC Immune Corp (ACIU)|Narx-foyda koeffitsiyenti Voyager Corp VYGR|P/E multiplikatori NMRA (Neumora Therapeutics)|P/E multiplikatori scilexholding.com SCLX|Tevogen Bio - P/E multiplikatori|Alpha Cognition (ACOG) - Narx-foyda koeffitsiyenti|CGTX: P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Inhibikase Pharma (IKT)|Narx-foyda koeffitsiyenti SAVA|P/E multiplikatori Assertio Therapeutics|Narx-foyda koeffitsiyenti COYA (Coya Therapeutics, Inc.)|Bozor narxining sof foydaga nisbati VTGN|P/E multiplikatori OVID (Ovid Therapeutics)|Biznesning o‘zini qoplash muddati Acumen Pharmaceuticals, Inc (ABOS)|CervoMed Inc. - P/E multiplikatori|Alterity Therapeutics (ATHE) - Narx-foyda koeffitsiyenti|CLNN: P/E multiplikatori|PepGen (PEPG) - P/E multiplikatori|Narxning foydaga nisbati Jupiter Neurosciences|Narxning foydaga nisbati RLMD|Narxning foydaga nisbati Annovis Bio, Inc. (ANVS)|Biznesning o‘zini qoplash muddati gracetx.com|P/E multiplikatori AIFF (Firefly Neuroscience)|P/E multiplikatori ANEW Medical KLTO|NRSN - Narxning foydaga nisbati|Reviva Pharmaceuticals, Inc. (RVPH) - Narx-foyda koeffitsiyenti|metaviatx.com (MTVA) - Narxning foydaga nisbati|NRXS (neuraxis.com) - Narxning foydaga nisbati|Narx-foyda koeffitsiyenti HSDT|Narx-foyda multiplikatori PASG (Passage Bio Corp)|Narxning foydaga nisbati Neuphoria Therapeutics Inc. (NEUP)|Minerva - Narx-foyda multiplikatori|P/E multiplikatori ATHA (Athira Pharma, Inc.)|addextherapeutics.com (ADXN) - Kapitalizatsiyaning foydaga nisbati|ALZN: Narx-foyda koeffitsiyenti|CYCN - P/E multiplikatori|protagenic.com (PTIX) - Narxning foydaga nisbati|Pasithea Therapeutics Corp. - Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati Cortigent Inc|Kapitalizatsiyaning foydaga nisbati avenuetx.com ATXI|P/E multiplikatori BCLI|P/E multiplikatori Cara Therapeutics Inc. (CARA)|Narxning foydaga nisbati Chromocell Therapeutics Corporation CHRO|ELYM - Narx-foyda koeffitsiyenti|ITCI: Narx-foyda koeffitsiyenti|Kapitalizatsiyaning foydaga nisbati longboardpharma.com|Marinus Pharmaceuticals, Inc. (MRNS) - Narxning foydaga nisbati|NKGN (NKGen Biotech Inc) - Narxning foydaga nisbati|Narx-foyda koeffitsiyenti NRBO|Kapitalizatsiyaning foydaga nisbati Sage Therapeutics Inc SAGE|Narx-foyda koeffitsiyenti SNPX (Synaptogenix, Inc.)|trevena.com - Narx-foyda multiplikatori|Vigil Neuroscience, Inc. - Narx-foyda koeffitsiyenti|Kompaniya qiymatining sof foydaga nisbati WENA|CERE - Narxning foydaga nisbati
